LaunchCyte Lands Interim Financing as it Gears Up for Launch of Morewood Molecular | GenomeWeb

Just one year after it was founded, Pittsburgh-based bioinformatics incubator LaunchCyte may have an early bloomer on its hands as it gears up for its first launch.

CEO Tom Petzinger told BioInform that LaunchCyte’s first portfolio company, Morewood Molecular Sciences, “is exceeding our expectations in terms of the pace of commercialization.”

LaunchCyte just closed on $700,000 of interim financing from a small number of individuals, of which $500,000 has been set aside to accelerate the commercialization of Morewood.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.